NYSE · Financial Statements

Bio-Rad Laboratories, Inc. (BIO) Financial Statements

$366.16 NYSE: BIO Market Cap $9.86B

Bio-Rad Laboratories, Inc. most recently reported annual revenue of $2.6B, net profit of $760.0M, revenue has compounded at 0.3% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.9B$2.8B$2.7B$2.6B$2.6B
Operating Profit$500.0M$483.0M$338.0M$269.0M$271.0M
Net Profit$4.3B$-3.6B$-637.0M$-1.8B$760.0M
EPS$140.83$-121.79$-21.82$-65.36$27.87
Op Margin17.1%17.2%12.7%10.5%10.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$17.8B$13.5B$12.3B$9.4B$10.6B
Total Liabilities$4.1B$3.9B$3.6B$2.8B$3.1B
Cash$471.0M$434.0M$404.0M$488.0M$532.0M
Borrowings$223.0M$1.4B$1.4B$1.4B$1.5B

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$669.0M$194.0M$375.0M$455.0M$532.0M
Investing Cash Flow$-931.0M$-1.3B$-136.0M$-349.0M$-347.0M
Financing Cash Flow$-52.0M$-212.0M$-425.0M$-218.0M$-298.0M
Net Cash Flow$-196.0M$-37.0M$-30.0M$85.0M$40.0M
Free Cash Flow$536.0M$80.0M$218.0M$266.0M$375.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.15
EV / EBITDA19.87
FCF Yield3.55%
Quick Ratio2.33
Interest Coverage6.40
Return 1Y21.80%
Return 3Y0.31%
Return 5Y-49.57%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
BIO Overview BIO Dividend Run Stock Screener